ACRV - Company ID 0001781174
Acrivon Therapeutics, Inc. trades as ACRV. This page tracks Acrivon Therapeutics, Inc. through 321 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-26 |
| Proxy materials | DEFA14A | 2026-05-22 |
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
The largest companies sharing Acrivon Therapeutics, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Acrivon Therapeutics, Inc. reported a net loss of $77.91M.